CD8+ T cells specific for immunodominant trans-sialidase epitopes contribute to control of trypanosoma cruzi infection but are not required for resistance

Journal of Immunology

Volumn 185, Issue 1, 2010, Pages 560-568

  Rosenberg, Charles S ^a   Martin, Diana L ^a,b   Tarleton, Rick L ^a  

^a UNIVERSITY OF GEORGIA   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANYLASPARAGINYLTYROSYLLYSYLPHENYLALANYLTHREONYLLEUCYLVALINE; EPITOPE; ISOLEUCYLTYROSYLASPARAGINYLVALYLGLYCYLGLUTAMINYLVALYLSERYLISOLEUCINE; SIALIDASE; UNCLASSIFIED DRUG; VALYLASPARAGINYLTYROSYLASPARTYLPHENYLALANYLTHREONYLLEUCYLVALINE; GLYCOPROTEIN; PEPTIDE FRAGMENT; TRANS SIALIDASE; TRANS-SIALIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CD8+ T LYMPHOCYTE; CHAGAS DISEASE; CONTROLLED STUDY; CYTOTOXICITY; FLOW CYTOMETRY; GENETIC CODE; IMMUNITY; IMMUNOLOGICAL TOLERANCE; INFECTION CONTROL; INFECTION RESISTANCE; LYMPHOCYTE SUBPOPULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN CELL; ACUTE DISEASE; ANIMAL; BAGG ALBINO MOUSE; C57BL MOUSE; ENZYMOLOGY; FEMALE; IMMUNOLOGY; INNATE IMMUNITY; LYMPHOCYTE DEPLETION; METHODOLOGY; PARASITOLOGY; T LYMPHOCYTE SUBPOPULATION;

ACUTE DISEASE; ANIMALS; CD8-POSITIVE T-LYMPHOCYTES; CHAGAS DISEASE; EPITOPES, T-LYMPHOCYTE; FEMALE; GLYCOPROTEINS; IMMUNE TOLERANCE; IMMUNITY, INNATE; IMMUNODOMINANT EPITOPES; LYMPHOCYTE DEPLETION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; NEURAMINIDASE; PEPTIDE FRAGMENTS; T-LYMPHOCYTE SUBSETS;

EID: 77956209421     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1000432     Document Type: Article

References (67)

1. Wong, P., and E. G. Pamer. 2003. CD8 T cell responses to infectious pathogens. Annu. Rev. Immunol. 21: 29-70.
2. Harty, J. T., A. R. Tvinnereim, and D. W. White. 2000. CD8+ T cell effector mechanisms in resistance to infection. Annu. Rev. Immunol. 18: 275-308.
3. Yewdell, J. W., and J. R. Bennink. 1999. Immunodominance in major histo-compatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17: 51-88.
4. Pamer, E. G. 2004. Immune responses to Listeria monocytogenes. Nat. Rev. Immunol. 4: 812-823.
5. Yewdell, J. W. 2006. Confronting complexity: real-world immunodominance in antiviral CD8+ T cell responses. Immunity 25: 533-543.
6. Blanchard, N., F. Gonzalez, M. Schaeffer, N. T. Joncker, T. Cheng, A. J. Shastri, E. A. Robey, and N. Shastri. 2008. Immunodominant, protective response to the parasite Toxoplasma gondii requires antigen processing in the endoplasmic reticulum. Nat. Immunol. 9: 937-944.
7. Kumar, K. A., G. Sano, S. Boscardin, R. S. Nussenzweig, M. C. Nussenzweig, F. Zavala, and V. Nussenzweig. 2006. The circumsporozoite protein is an immunodominant protective antigen in irradiated sporozoites. Nature 444: 937-940.
8. Martin, D. L., D. B. Weatherly, S. A. Laucella, M. A. Cabinian, M. T. Crim, S. Sullivan, M. Heiges, S. H. Craven, C. S. Rosenberg, M. H. Collins, et al. 2006. CD8+ T-Cell responses to Trypanosoma cruzi are highly focused on strain-variant trans-sialidase epitopes. PLoS Pathog. 2: e77.
9. Doolan, D. L., S. Southwood, D. A. Freilich, J. Sidney, N. L. Graber, L. Shatney, L. Bebris, L. Florens, C. Dobano, A. A. Witney, et al. 2003. Identification of Plasmodium falciparum antigens by antigenic analysis of genomic and proteomic data. Proc. Natl. Acad. Sci. USA 100: 9952-9957.
10. Frickel, E. M., N. Sahoo, J. Hopp, M. J. Gubbels, M. P. Craver, L. J. Knoll, H. L. Ploegh, and G. M. Grotenbreg. 2008. Parasite stage-specific recognition of endogenous Toxoplasma gondii-derived CD8+ T cell epitopes. J. Infect. Dis. 198: 1625-1633.
11. Coppel, R. L., and C. G. Black. 2005. Parasite genomes. Int. J. Parasitol. 35: 465-479.
12. El-Sayed, N. M., P. J. Myler, D. C. Bartholomeu, D. Nilsson, G. Aggarwal, A. N. Tran, E. Ghedin, E. A. Worthey, A. L. Delcher, G. Blandin, et al. 2005. The genome sequence of Trypanosoma cruzi, etiologic agent of Chagas disease. Science 309: 409-415.
13. Tzelepis, F., B. C. de Alencar, M. L. Penido, C. Claser, A. V. Machado, O. Bruna-Romero, R. T. Gazzinelli, and M. M. Rodrigues. 2008. Infection with Trypanosoma cruzi restricts the repertoire of parasite-specific CD8+ T cells leading to immunodominance. J. Immunol. 180: 1737-1748.
14. Shin, H., and E. J. Wherry. 2007. CD8 T cell dysfunction during chronic viral infection. Curr. Opin. Immunol. 19: 408-415.
15. Martin, D. L., and R. L. Tarleton. 2005. Antigen-specific T cells maintain an effector memory phenotype during persistent Trypanosoma cruzi infection. J. Immunol. 174: 1594-1601.
16. Bustamante, J. M., L. M. Bixby, and R. L. Tarleton. 2008. Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease. Nat. Med. 14: 542-550.
17. Hoft, D. F., C. S. Eickhoff, O. K. Giddings, J. R. Vasconcelos, and M. M. Rodrigues. 2007. Trans-sialidase recombinant protein mixed with CpG motif-containing oligodeoxynucleotide induces protective mucosal and systemic trypanosoma cruzi immunity involving CD8+ CTL and B cell-mediated cross-priming. J. Immunol. 179: 6889-6900.
18. Bixby, L. M., and R. L. Tarleton. 2008. Stable CD8+ T cell memory during persistent Trypanosoma cruzi infection. J. Immunol. 181: 2644-2650.
19. Frasch, A. C. 2000. Functional diversity in the trans-sialidase and mucin families in Trypanosoma cruzi. Parasitol. Today 16: 282-286.
20. Miyahira, Y., Y. Takashima, S. Kobayashi, Y. Matsumoto, T. Takeuchi, M. Ohyanagi-Hara, A. Yoshida, A. Ohwada, H. Akiba, H. Yagita, et al. 2005. Immune responses against a single CD8+-T-cell epitope induced by virus vector vaccination can successfully control Trypanosoma cruzi infection. Infect. Immun. 73: 7356-7365.
21. Araújo, A. F., B. C. de Alencar, J. R. Vasconcelos, M. I. Hiyane, C. R. Marinho, M. L. Penido, S. B. Boscardin, D. F. Hoft, R. T. Gazzinelli, and M. M. Rodrigues. 2005. CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2. Infect. Immun. 73: 6017-6025.
22. Atwood, J. A., III, D. B. Weatherly, T. A. Minning, B. Bundy, C. Cavola, F. R. Opperdoes, R. Orlando, and R. L. Tarleton. 2005. The Trypanosoma cruzi proteome. Science 309: 473-476.
23. Rodrigues, M. M., B. C. Alencar, C. Claser, and F. Tzelepis. 2009. Immunodominance: a new hypothesis to explain parasite escape and host/parasite equilibrium leading to the chronic phase of Chagas' disease? Braz. J. Med. Biol. Res. 42: 220-223.
24. Martin, D., and R. Tarleton. 2004. Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection. Immunol. Rev. 201: 304-317.
25. Millar, A. E., M. Wleklinski-Lee, and S. J. Kahn. 1999. The surface protein superfamily of Trypanosoma cruzi stimulates a polarized Th1 response that becomes anergic. J. Immunol. 162: 6092-6099.
26. Tarleton, R. L. 2007. Immune system recognition of Trypanosoma cruzi. Curr. Opin. Immunol. 19: 430-434.
27. Cummings, K. L., and R. L. Tarleton. 2003. Rapid quantitation of Trypanosoma cruzi in host tissue by real-time PCR. Mol. Biochem. Parasitol. 129: 53-59.
28. Aichele, P., K. Brduscha-Riem, S. Oehen, B. Odermatt, R. M. Zinkernagel, H. Hengartner, and H. Pircher. 1997. Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology. Immunity 6: 519-529. (Pubitemid 27239343)
29. Redmond, W. L., B. C. Marincek, and L. A. Sherman. 2005. Distinct requirements for deletion versus anergy during CD8 T cell peripheral tolerance in vivo. J. Immunol. 174: 2046-2053.
30. Johnson, A. J., J. Upshaw, K. D. Pavelko, M. Rodriguez, and L. R. Pease. 2001. Preservation of motor function by inhibition of CD8+ virus peptide-specific T cells in Theiler's virus infection. FASEB J. 15: 2760-2762.
31. Mendez-Fernandez, Y. V., A. J. Johnson, M. Rodriguez, and L. R. Pease. 2003. Clearance of Theiler's virus infection depends on the ability to generate a CD8+ T cell response against a single immunodominant viral peptide. Eur. J. Immunol. 33: 2501-2510.
32. Howe, C. L., D. Ure, J. D. Adelson, R. LaFrance-Corey, A. Johnson, and M. Rodriguez. 2007. CD8+ T cells directed against a viral peptide contribute to loss of motor function by disrupting axonal transport in a viral model of fulminant demyelination. J. Neuroimmunol. 188: 13-21.
33. van der Most, R. G., K. Murali-Krishna, J. G. Lanier, E. J. Wherry, M. T. Puglielli, J. N. Blattman, A. Sette, and R. Ahmed. 2003. Changing immunodominance patterns in antiviral CD8 T-cell responses after loss of epitope presentation or chronic antigenic stimulation. Virology 315: 93-102.
34. Webby, R. J., S. Andreansky, J. Stambas, J. E. Rehg, R. G. Webster, P. C. Doherty, and S. J. Turner. 2003. Protection and compensation in the influenza virus-specific CD8+ T cell response. Proc. Natl. Acad. Sci. USA 100: 7235-7240.
35. Andreansky, S. S., J. Stambas, P. G. Thomas, W. Xie, R. J. Webby, and P. C. Doherty. 2005. Consequences of immunodominant epitope deletion for minor influenza virus-specific CD8+-T-cell responses. J. Virol. 79: 4329-4339.
36. Thomas, P. G., S. A. Brown, R. Keating, W. Yue, M. Y. Morris, J. So, R. J. Webby, and P. C. Doherty. 2007. Hidden epitopes emerge in secondary influenza virus-specific CD8+ T cell responses. J. Immunol. 178: 3091-3098.
37. Kotner, J., and R. Tarleton. 2007. Endogenous CD4(+) CD25(+) regulatory T cells have a limited role in the control of Trypanosoma cruzi infection in mice. Infect. Immun. 75: 861-869.
38. Couper, K. N., D. G. Blount, and E. M. Riley. 2008. IL-10: the master regulator of immunity to infection. J. Immunol. 180: 5771-5777.
39. Tarleton, R. L. 1990. Depletion of CD8+ T cells increases susceptibility and reverses vaccine-induced immunity in mice infected with Trypanosoma cruzi. J. Immunol. 144: 717-724.
40. Tarleton, R. L., B. H. Koller, A. Latour, and M. Postan. 1992. Susceptibility of beta 2-microglobulin-deficient mice to Trypanosoma cruzi infection. Nature 356: 338-340.
41. Tarleton, R. L., M. J. Grusby, M. Postan, and L. H. Glimcher. 1996. Trypanosoma cruzi infection in MHC-deficient mice: further evidence for the role of both class I- and class II-restricted T cells in immune resistance and disease. Int. Immunol. 8: 13-22.
42. Tzelepis, F., B. C. de Alencar, M. L. Penido, R. T. Gazzinelli, P. M. Persechini, and M. M. Rodrigues. 2006. Distinct kinetics of effector CD8+ cytotoxic T cells after infection with Trypanosoma cruzi in naive or vaccinated mice. Infect. Immun. 74: 2477-2481.
43. Gallimore, A., J. Hombach, T. Dumrese, H. G. Rammensee, R. M. Zinkernagel, and H. Hengartner. 1998. A protective cytotoxic T cell response to a subdominant epitope is influenced by the stability of the MHC class I/peptide complex and the overall spectrum of viral peptides generated within infected cells. Eur. J. Immunol. 28: 3301-3311.
44. Moskophidis, D., and R. M. Zinkernagel. 1995. Immunobiology of cytotoxic T-cell escape mutants of lymphocytic choriomeningitis virus. J. Virol. 69: 2187-2193.
45. Pircher, H., D. Moskophidis, U. Rohrer, K. Bürki, H. Hengartner, and R. M. Zinkernagel. 1990. Viral escape by selection of cytotoxic T cell-resistant virus variants in vivo. Nature 346: 629-633.
46. Stock, A. T., C. M. Jones, W. R. Heath, and F. R. Carbone. 2006. CTL response compensation for the loss of an immunodominant class I-restricted HSV-1 determinant. Immunol. Cell Biol. 84: 543-550.
47. Vallbracht, S., B. Jessen, S. Mrusek, A. Enders, P. L. Collins, S. Ehl, and C. D. Krempl. 2007. Influence of a single viral epitope on T cell response and disease after infection of mice with respiratory syncytial virus. J. Immunol. 179: 8264-8273.
48. Weidt, G., O. Utermöhlen, J. Heukeshoven, F. Lehmann-Grube, and W. Deppert. 1998. Relationship among immunodominance of single CD8+ T cell epitopes, virus load, and kinetics of primary antiviral CTL response. J. Immunol. 160: 2923-2931.
49. Vijh, S., I. M. Pilip, and E. G. Pamer. 1999. Noncompetitive expansion of cytotoxic T lymphocytes specific for different antigens during bacterial infection. Infect. Immun. 67: 1303-1309.
50. Getts, M. T., B. S. Kim, and S. D. Miller. 2007. Differential outcome of tolerance induction in naive versus activated Theiler's virus epitope-specific CD8+ cytotoxic T cells. J. Virol. 81: 6584-6593.
51. Lin, X., M. K. Njenga, A. J. Johnson, K. D. Pavelko, C. S. David, L. R. Pease, and M. Rodriguez. 2002. Transgenic expression of Theiler's murine encephalomyelitis virus genes in H-2(b) mice inhibits resistance to virus-induced demyelination. J. Virol. 76: 7799-7811. (Pubitemid 34761002)
52. Myoung, J., Y. Y. Bahk, H. S. Kang, M. C. Dal Canto, and B. S. Kim. 2008. Anticapsid immunity level, not viral persistence level, correlates with the progression of Theiler's virus-induced demyelinating disease in viral P1-transgenic mice. J. Virol. 82: 5606-5617.
53. Pavelko, K. D., L. R. Pease, C. S. David, and M. Rodriguez. 2007. Genetic deletion of a single immunodominant T-cell response confers susceptibility to virus-induced demyelination. Brain Pathol. 17: 184-196.
54. Schildknecht, A., S. Welti, M. B. Geuking, L. Hangartner, and M. van den Broek. 2008. Absence of CTL responses to early viral antigens facilitates viral persistence. J. Immunol. 180: 3113-3121.
55. von Herrath, M., B. Coon, D. Homann, T. Wolfe, and L. G. Guidotti. 1999. Thymic tolerance to only one viral protein reduces lymphocytic choriomeningitis virus-induced immunopathology and increases survival in perforin-deficient mice. J. Virol. 73: 5918-5925.
56. El-Sayed, N. M., P. J. Myler, G. Blandin, M. Berriman, J. Crabtree, G. Aggarwal, E. Caler, H. Renauld, E. A. Worthey, C. Hertz-Fowler, et al. 2005. Comparative genomics of trypanosomatid parasitic protozoa. Science 309: 404-409.
57. Deitsch, K. W., S. A. Lukehart, and J. R. Stringer. 2009. Common strategies for antigenic variation by bacterial, fungal and protozoan pathogens. Nat. Rev. Microbiol. 7: 493-503.
58. Garg, N., M. P. Nunes, and R. L. Tarleton. 1997. Delivery by Trypanosoma cruzi of proteins into the MHC class I antigen processing and presentation pathway. J. Immunol. 158: 3293-3302.
59. Kahn, S. J., and M. Wleklinski. 1997. The surface glycoproteins of Trypanosoma cruzi encode a superfamily of variant T cell epitopes. J. Immunol. 159: 4444-4451.
60. Stuart, K., R. Brun, S. Croft, A. Fairlamb, R. E. Gürtler, J. McKerrow, S. Reed, and R. Tarleton. 2008. Kinetoplastids: related protozoan pathogens, different diseases. J. Clin. Invest. 118: 1301-1310.
61. Haolla, F. A., C. Claser, B. C. de Alencar, F. Tzelepis, J. R. de Vasconcelos, G. de Oliveira, J. C. Silvério, A. V. Machado, J. Lannes-Vieira, O. Bruna-Romero, et al. 2009. Strain-specific protective immunity following vaccination against experimental Trypanosoma cruzi infection. Vaccine 27: 5644-5653.
62. Pays, E., L. Vanhamme, and D. Pérez-Morga. 2004. Antigenic variation in Trypanosoma brucei: facts, challenges and mysteries. Curr. Opin. Microbiol. 7: 369-374.
63. Miyahira, Y. 2008. Trypanosoma cruzi infection from the view of CD8+ T cell immunity - an infection model for developing T cell vaccine. Parasitol. Int. 57: 38-48.
64. Alvarez, M. G., M. Postan, D. B. Weatherly, M. C. Albareda, J. Sidney, A. Sette, C. Olivera, A. H. Armenti, R. L. Tarleton, and S. A. Laucella. 2008. HLA Class I-T cell epitopes from trans-sialidase proteins reveal functionally distinct subsets of CD8+ T cells in chronic Chagas disease. PLoS Negl. Trop. Dis. 2: e288.
65. Wizel, B., M. Palmieri, C. Mendoza, B. Arana, J. Sidney, A. Sette, and R. Tarleton. 1998. Human infection with Trypanosoma cruzi induces parasite antigen-specific cytotoxic T lymphocyte responses. J. Clin. Invest. 102: 1062-1071.
66. Millar, A. E., and S. J. Kahn. 2000. The SA85-1.1 protein of the Trypanosoma cruzi trans-sialidase superfamily is a dominant T-cell antigen. Infect. Immun. 68: 3574-3580.
67. Douradinha, B., M. M. Mota, A. J. Luty, and R. W. Sauerwein. 2008. Cross-species immunity in malaria vaccine development: two, three, or even four for the price of one? Infect. Immun. 76: 873-878.